Next Century Growth Investors’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-769,808
Closed -$10M 133
2024
Q1
$10M Buy
769,808
+409,319
+114% +$5.46M 0.87% 37
2023
Q4
$4.6M Sell
360,489
-152,249
-30% -$1.54M 0.45% 63
2023
Q3
$6.72M Sell
512,738
-1,068,896
-68% -$19.6M 0.73% 42
2023
Q2
$40.5M Buy
1,581,634
+44,363
+3% +$1.15M 3.9% 2
2023
Q1
$38.7M Sell
1,537,271
-58,116
-4% -$1.36M 4.26% 1
2022
Q4
$36.7M Buy
1,595,387
+20,018
+1% +$461K 4.4% 2
2022
Q3
$34.8M Sell
1,575,369
-165,785
-10% -$3.21M 4.24% 1
2022
Q2
$25M Buy
1,741,154
+53,304
+3% +$898K 3.26% 5
2022
Q1
$31.9M Buy
1,687,850
+152,240
+10% +$2.96M 3.19% 3
2021
Q4
$28.6M Buy
1,535,610
+452,227
+42% +$9.33M 2.58% 6
2021
Q3
$29.1M Buy
1,083,383
+89,032
+9% +$2.45M 2.52% 7
2021
Q2
$31.1M Buy
+994,351
New +$31.7M 2.43% 8

Other funds holding TMCI

Next Century Growth Investors's TMCI Position: Q2 2024 in Review

Next Century Growth Investors sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 769,808 shares — an estimated $10M sold.

Next Century Growth Investors first reported a position in TMCI in Q2 2021 and held it in 12 quarters. The position peaked at $40.5M in Q2 2023. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • Next Century Growth Investors reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • Next Century Growth Investors sold 769,808 Treace Medical Concepts shares in Q2 2024, an estimated $10M.
  • Next Century Growth Investors first reported a position in Treace Medical Concepts in Q2 2021 and held it in 12 quarters.
  • Next Century Growth Investors's Treace Medical Concepts position peaked at $40.5M in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Next Century Growth Investors's 13F filing for Q2 2024, filed 14 Aug 2024.